Clinical research - Press Releases

Date	Title	Company
08-Dec-2020	Loxo Oncology at Lilly Announces Updated Data from the Phase 1/2 BRUIN Clinical Trial for LOXO-305 in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma at the American Society of Hematology Annual Meeting	Loxo Oncology at Lilly
08-Dec-2020	Amgen And Novartis Partner With Karamo Brown To Support And Empower People Living With Migraine	Amgen
08-Dec-2020	Bristol Myers Squibb Presents Analyses from Pivotal QUAZAR® AML-001 Study of Onureg® (azacitidine tablets; CC-486) in Adults with Acute Myeloid Leukemia in First Remission	Bristol Myers Squibb
08-Dec-2020	Calquence data across four trials reinforces cardiovascular safety profile in patients with chronic lymphocytic leukaemia	AstraZeneca
08-Dec-2020	osteolabs GmbH Successfully Closes Second Financing Round of Nearly 1.6 Million EUR	osteolabs GmbH
08-Dec-2020	Hofseth Biocare ASA: HBC and DKSH announce a Pan-Asian exclusive collaboration for distribution of HBC branded products including across China, India, Japan & Korea	Hofseth BioCare ASA
08-Dec-2020	Chi-Med Hosts Ground-breaking Ceremony for a Large-Scale Manufacturing Plant in Zhangjiang, Shanghai	Chi-Med
08-Dec-2020	Pioneering COVID-19 Test Detects Virus with Smartphone	Two-Photon Research Inc
08-Dec-2020	First-In-Human Heart Failure Data of Cardior Pharmaceuticals´ Novel miRNA Antisense Therapy Presented at the 17th Global Cardiovascular Clinical Trialists Forum	Cardior Pharmaceuticals
08-Dec-2020	OHMX.bio and Fujirebio Europe Receive Grant of 720K EURO to Incorporate Third Generation Sequencing into Clinical In Vitro Diagnostics Platform	OHMX.bio
07-Dec-2020	Medigene AG: Detailed analysis from Medigene's completed Phase I/II DC vaccine in AML patients presented orally at ASH 2020	Medigene
07-Dec-2020	Transgene appoints Hedi Ben Brahim as Chairman and Chief Executive Officer	Transgene
07-Dec-2020	Stress and anxiety levels increasing in NHS staff during COVID-19	Nuance
07-Dec-2020	Moberg Pharma publishes prospectus relating to the rights issue	Moberg Pharma AB
07-Dec-2020	Kaia Health and Chiesi Group Announce Strategic Partnership to Commercialise Kaia COPD Pulmonary Rehabilitation App in European Markets	Kaia Health
07-Dec-2020	Biophytis –Upcoming Potential Value Generating Milestones	Biophytis SA
06-Dec-2020	MAGROLIMAB DEMONSTRATES CLINICAL RESPONSES IN ONGOING PHASE 1B TRIAL OF PREVIOUSLY UNTREATED ACUTE MYELOID LEUKAEMIA PATIENTS	Gilead Sciences, Inc.
06-Dec-2020	NEW FOUR-YEAR DATA SHOW LONG-TERM SURVIVAL IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA TREATED WITH YESCARTA® (AXICABTAGENE CILOLEUCEL) IN ZUMA-1 TRIAL	Kite, A Gilead Company
06-Dec-2020	YESCARTA® (AXICABTAGENE CILOLEUCEL) IS FIRST CAR T CELL THERAPY TO DEMONSTRATE HIGH RESPONSE RATES AND DURABLE CLINICAL BENEFIT IN A PIVOTAL INDOLENT NON-HODGKIN LYMPHOMA STUDY	Kite, A Gilead Company
05-Dec-2020	Trending Now: AI Smart Baby Monitors Market Global Industry Size, Growth, Segments, Revenue, Manufacturers & Forecast Research Report	Alexa Reports